Quantbot Technologies LP Tricida, Inc. Transaction History

Quantbot Technologies LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$8.51 - $13.6 $46,983 - $75,085	5,521 New	5,521 $57,000
Q2 2022 Aug 09, 2022	SELL	$7.31 - $11.85 $40,358 - $65,423	-5,521 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$7.35 - $10.63 $40,579 - $58,688	5,521 New	5,521 $45,000
Q1 2021 May 14, 2021	SELL	$4.52 - $7.8 $5,753 - $9,929	-1,273 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$4.37 - $9.46 $3,146 - $6,811	-720 Reduced 36.13%	1,273 $8,000
Q3 2020 Nov 16, 2020	BUY	$8.56 - $26.93 $11,068 - $34,820	1,293 Added 184.71%	1,993 $18,000
Q2 2020 Aug 13, 2020	BUY	$21.21 - $31.55 $14,847 - $22,085	700 New	700 $19,000
Q1 2020 May 13, 2020	SELL	$18.43 - $38.04 $39,034 - $80,568	-2,118 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$29.6 - $43.71 $36,437 - $53,807	1,231 Added 138.78%	2,118 $79,000
Q3 2019 Nov 12, 2019	BUY	$29.87 - $42.22 $26,494 - $37,449	887 New	887 $27,000

30K

124K

46.5K

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.